Jiaping Peng

534 total citations
19 papers, 392 citations indexed

About

Jiaping Peng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jiaping Peng has authored 19 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Jiaping Peng's work include MicroRNA in disease regulation (4 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Epigenetics and DNA Methylation (2 papers). Jiaping Peng is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Epigenetics and DNA Methylation (2 papers). Jiaping Peng collaborates with scholars based in China, United States and India. Jiaping Peng's co-authors include Shu Zheng, Suzhan Zhang, Yun Yen, Peiguo Chu, Lily Lai, Sofia Loera, Xiyong Liu, Lun Zhou, Ying Yuan and Lirong Chen and has published in prestigious journals such as Clinical Cancer Research, World Journal of Gastroenterology and Oncotarget.

In The Last Decade

Jiaping Peng

19 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiaping Peng China 9 248 185 106 55 49 19 392
Yong Gu China 10 324 1.3× 181 1.0× 100 0.9× 28 0.5× 38 0.8× 14 469
Lanshan Huang China 12 198 0.8× 148 0.8× 81 0.8× 33 0.6× 22 0.4× 24 352
Daniel Onofre Vidal Brazil 13 389 1.6× 226 1.2× 63 0.6× 33 0.6× 87 1.8× 31 530
Yu Yin China 13 329 1.3× 254 1.4× 106 1.0× 39 0.7× 47 1.0× 30 525
Songwang Cai China 13 315 1.3× 186 1.0× 154 1.5× 43 0.8× 80 1.6× 33 516
A Koch Germany 8 180 0.7× 96 0.5× 80 0.8× 38 0.7× 38 0.8× 11 339
Jue‐Yu Zhou China 15 426 1.7× 278 1.5× 110 1.0× 34 0.6× 38 0.8× 42 591
Zhuqing Zhou China 14 329 1.3× 205 1.1× 150 1.4× 34 0.6× 57 1.2× 26 529
Jorge Zerón-Medina United Kingdom 9 267 1.1× 113 0.6× 173 1.6× 39 0.7× 53 1.1× 16 436
Jiangfeng Xu China 11 289 1.2× 235 1.3× 71 0.7× 42 0.8× 67 1.4× 18 486

Countries citing papers authored by Jiaping Peng

Since Specialization
Citations

This map shows the geographic impact of Jiaping Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaping Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaping Peng more than expected).

Fields of papers citing papers by Jiaping Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiaping Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaping Peng. The network helps show where Jiaping Peng may publish in the future.

Co-authorship network of co-authors of Jiaping Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Jiaping Peng. A scholar is included among the top collaborators of Jiaping Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiaping Peng. Jiaping Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Yu, Wei, Xiaoqiu Ren, Chunxiu Hu, et al.. (2019). Glioma SOX2 expression decreased after adjuvant therapy. BMC Cancer. 19(1). 1087–1087. 16 indexed citations
2.
Li, Xiaofen, Wangxiong Hu, Jiaojiao Zhou, et al.. (2017). CLCA1 suppresses colorectal cancer aggressiveness via inhibition of the Wnt/beta-catenin signaling pathway. Cell Communication and Signaling. 15(1). 38–38. 58 indexed citations
3.
Zhang, Cen, Juan Liu, Xuetian Yue, et al.. (2016). microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis. Oncotarget. 7(8). 8783–8796. 33 indexed citations
4.
Hu, Hanguang, Hang Zhang, Weiting Ge, et al.. (2012). Secreted Protein Acidic and Rich in Cysteines-like 1 Suppresses Aggressiveness and Predicts Better Survival in Colorectal Cancers. Clinical Cancer Research. 18(19). 5438–5448. 38 indexed citations
5.
Peng, Jiaping & Qun Meng. (2012). Abstract B104: Expressions of PCNA in triple negative breast cancers and Their clinical significance. Cancer Prevention Research. 5(11_Supplement). B104–B104. 1 indexed citations
6.
Wang, Xiaochen, Xiyong Liu, Lirong Chen, et al.. (2011). Overexpression of HMGA2 Promotes Metastasis and Impacts Survival of Colorectal Cancers. Clinical Cancer Research. 17(8). 2570–2580. 151 indexed citations
7.
Liu, Hong, et al.. (2008). [Effect of microRNA143 expression on cell proliferation in colonic carcinoma].. PubMed. 30(7). 498–501. 4 indexed citations
8.
Zheng, Shu, Jimin Shao, Qi Dong, Jiaping Peng, & Suzhan Zhang. (2005). Characterization of ST13 Protein Expression in Human Colorectal Cancer Tissues. The Chinese-German Journal of Clinical Oncology. 4(1). 2–7. 3 indexed citations
9.
Zhang, Suzhan, et al.. (2005). Preparation and in vitro studies of microencapsulated cells releasing human tissue inhibitor of metalloproteinase-2. Journal of Zhejiang University SCIENCE A. 6B(9). 859–864. 2 indexed citations
10.
Peng, Jiaping, et al.. (2005). Application of new tissue microarrayer−ZM-1 without recipient paraffin block. Journal of Zhejiang University SCIENCE A. 6B(9). 853–858. 7 indexed citations
11.
Peng, Jiaping, et al.. (2005). Prognostic significance of bcl-2 and p53 expression in colorectal carcinoma. Journal of Zhejiang University SCIENCE B. 6(12). 1163–1169. 32 indexed citations
12.
Song, Zhenya, et al.. (2005). [Clinical analysis of 39 cases of heterotopic gastric mucosa in the upper esophagus].. PubMed. 85(4). 244–7. 7 indexed citations
13.
Zheng, Shu, et al.. (2005). [Effects of microencapsulated CHO cells modified with maspin gene on the motility and adhesiveness of breast carcinoma cells Bcap37].. PubMed. 27(6). 342–6. 1 indexed citations
14.
Han, Mingyong, Jinming Yu, Shu Zheng, et al.. (2004). Serum interleukin-18 level as a prognostic marker in patients with colorectal carcinoma. Chinese Journal of Cancer Research. 16(2). 127–130. 1 indexed citations
15.
Peng, Jiaping, et al.. (2004). Significance of vascular endothelial growth factor expression and its correlation with inducible nitric oxide synthase in gastric cancer. World Journal of Gastroenterology. 10(9). 1250–1250. 11 indexed citations
16.
Han, Mingyong, et al.. (2004). Study on interleukin-18 gene transfer into human breast cancer cells to prevent tumorigenicity. Journal of Zhejiang University. Science A. 5(4). 472–476. 12 indexed citations
17.
Peng, Jiaping, Shu Zheng, Zuoxiang Xiao, & Suzhan Zhang. (2003). Inducible nitric oxide synthase expression is related to angiogenesis, bcl-2 and cell proliferation in hepatocellular carcinoma. Journal of Zhejiang University. Science A. 4(2). 221–227. 10 indexed citations
18.
Zheng, Shu, et al.. (2003). [Expression and recombination mechanism of SNC73 (IgHalpha1) in human epithelial cancer cell line].. PubMed. 83(17). 1493–6. 4 indexed citations
19.
Sun, Lifeng, et al.. (2003). [The study of 5-Aza-2'-deoxycytidine on transcription regulation of p16/CDKN2 gene demethylation in RKO human colorectal cell line].. PubMed. 83(23). 2077–82. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026